IMBiotechnologies Announces Supply Agreement With Embol Experts

IMBiotechnologies Ltd., a company based in Edmonton, recently announced that it has signed a supply agreement with Embol Experts, LLC, an influential group purchasing organization in the United States. This agreement pertains to the distribution of Ekobi® microspheres, a biodegradable and ultrasound-detectable embolic agent intended for clinics specializing in minimally invasive procedures. Ekobi® is approved in the United States and Canada for the treatment of hypervascularized tumors and other specific medical conditions.

Embol Experts highlights the uniqueness and benefits of Ekobi® microspheres in terms of safety and effectiveness in the provided treatments. This collaboration is also celebrated by IMBiotechnologies, anticipating an expansion in the use of their product. IMBiotechnologies specializes in the commercialization of medical products for embolotherapy, aiming to improve quality of life and treat various diseases.